Skip to main content
Log in

Clinical significance of FABP2 expression in newborns with necrotizing enterocolitis

  • Meta-analysis
  • Published:
World Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Background

This meta-analysis aimed to determine the role of human fatty acid binding protein 2 (FABP2) expression in the diagnosis of necrotizing enterocolitis (NEC) of newborns.

Data sources

Eligible studies for further statistical analysis were identified from various databases including PubMed, Expert Medica Database, Web of Science, Cochrane Library, Google Scholar, China BioMedicine and China National Knowledge Infrastructure. Random effects model was used, and summary standardized mean difference (SMD) with its 95% confidence interval (CI) was calculated to assess the association of FABP2 expression and NEC.

Results

Ten articles which included 572 infants (262 infants with NEC and 310 healthy controls) were included in the current meta-analysis. FABP2 showed a positive relationship with NEC of newborns (SMD=2.88, 95% CI=2.09-3.67, P<0.001). And FABP2 expression was higher in patients with advanced stage of NEC (stage III or stage II+III) than in those with early stage of NEC (stage I) (SMD=-0.48, 95% CI=-0.87 to -0.09, P=0.015). Ethnicity-stratified analysis yielded significantly different estimates with a high FABP2 expression in NEC in both Caucasians (SMD=3.16, 95% CI=1.90-4.43, P<0.001) and Asians (SMD=2.57, 95% CI=1.50-3.64, P<0.001). Sample-based subgroup analysis showed that FABP2 expression was positively correlated with neonatal NEC in both urinary- and blood-sample subgroups (all P<0.05).

Conclusion

The results prove that the high FABP2 expression is related to the damage to intestinal cells, which may be a possible early detection marker identifying neonatal NEC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Panigrahi P. Necrotizing enterocolitis: a practical guide to its prevention and management. Paediatr Drugs 2006;8:151–165.

    Article  PubMed  Google Scholar 

  2. Josefsson S, Bunn SK, Domellöf M. Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr 2007;44:407–413.

    Article  CAS  PubMed  Google Scholar 

  3. Björkström MV, Hall L, Söderlund S, Håkansson EG, Håkansson S, Domellöf M. Intestinal flora in very low-birth weight infants. Acta Paediatr 2009;98:1762–1767.

    Article  PubMed  Google Scholar 

  4. Däbritz J, Jenke A, Wirth S, Foell D. Fecal phagocyte-specific S100A12 for diagnosing necrotizing enterocolitis. J Pediatr 2012;161:1059–1064.

    Article  PubMed  Google Scholar 

  5. Okogbule-Wonodi AC, Gross GW, Sun CC, Agthe AG, Xiao L, Waites KB, et al. Necrotizing enterocolitis is associated with ureaplasma colonization in preterm infants. Pediatr Res 2011;69:442–447.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Terrin G, Passariello A, De Curtis M, Paludetto R, Berni Canani R. S100 A8/A9 protein as a marker for early diagnosis of necrotising enterocolitis in neonates. Arch Dis Child 2012;97:1102.

    Article  PubMed  Google Scholar 

  7. Gregory KE, Winston AB, Yamamoto HS, Dawood HY, Fashemi T, Fichorova RN, et al. Urinary intestinal fatty acid binding protein predicts necrotizing enterocolitis. J Pediatr 2014;164:1486–1488.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Afrazi A, Sodhi CP, Richardson W, Neal M, Good M, Siggers R, et al. New insights into the pathogenesis and treatment of necrotizing enterocolitis: Toll-like receptors and beyond. Pediatr Res 2011;69:183–188.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Reisinger KW, Elst M, Derikx JP, Nikkels PG, De Vries B, Adriaanse MP, et al. Intestinal fatty acid-binding protein: a possible marker for gut maturation. Pediatr Res 2014;76:261–268.

    Article  CAS  PubMed  Google Scholar 

  10. Schurink M, Scholten IG, Kooi EM, Hulzebos CV, Kox RG, Groen H, et al. Intestinal fatty acid-binding protein in neonates with imminent necrotizing enterocolitis. Neonatology 2014;106:49–54.

    Article  CAS  PubMed  Google Scholar 

  11. Briana DD, Liosi S, Gourgiotis D, Boutsikou M, Baka S, Marmarinos A, et al. Cord blood intestinal fatty acid-binding protein (I-FABP) in full-term intrauterine growth restricted pregnancies. J Matern Fetal Neonatal Med 2012;25:2062–2065.

    Article  CAS  PubMed  Google Scholar 

  12. Aydemir C, Dilli D, Oguz SS, Ulu HO, Uras N, Erdeve O, et al. Serum intestinal fatty acid binding protein level for early diagnosis and prediction of severity of necrotizing enterocolitis. Early Hum Dev 2011;87:659–661.

    Article  CAS  PubMed  Google Scholar 

  13. Evennett NJ, Hall NJ, Pierro A, Eaton S. Urinary intestinal fatty acid-binding protein concentration predicts extent of disease in necrotizing enterocolitis. J Pediatr Surg 2010;45:735–740.

    Article  PubMed  Google Scholar 

  14. Rowland A, Knights KM, Mackenzie PI, Miners JO. Characterization of the binding of drugs to human intestinal fatty acid binding protein (IFABP): potential role of IFABP as an alternative to albumin for in vitro-in vivo extrapolation of drug kinetic parameters. Drug Metab Dispos 2009;37:1395–1403.

    Article  CAS  PubMed  Google Scholar 

  15. Reisinger KW, Derikx JP, Thuijls G, van der Zee DC, Brouwers HA, Van Bijnen AA, et al. Noninvasive measurement of intestinal epithelial damage at time of refeeding can predict clinical outcome after necrotizing enterocolitis. Pediatr Res 2013;73:209–213.

    Article  CAS  PubMed  Google Scholar 

  16. Thuijls G, Derikx JP, Van Wijck K, Zimmermann LJ, Degraeuwe PL, Mulder TL, et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg 2010;251:1174–1180.

    Article  PubMed  Google Scholar 

  17. Wiercinska-Drapalo A, Jaroszewicz J, Siwak E, Pogorzelska J, Prokopowicz D. Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis. Regul Pept 2008;147:25–28.

    Article  CAS  PubMed  Google Scholar 

  18. Derikx JP, Vreugdenhil AC, Van den Neucker AM, Grootjans J, Van Bijnen AA, Damoiseaux JG, et al. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. J Clin Gastroenterol 2009;43:727–733.

    Article  PubMed  Google Scholar 

  19. Ng EW, Poon TC, Lam HS, Cheung HM, Ma TP, Chan KY, et al. Gut-associated biomarkers L-FABP, I-FABP, and TFF3 and LIT score for diagnosis of surgical necrotizing enterocolitis in preterm infants. Ann Surg 2013;258:1111–1118.

    Article  PubMed  Google Scholar 

  20. Reisinger KW, van der Zee DC, Brouwers HA, Kramer BW, Van Heurn LW, Buurman WA, et al. Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis. J Pediatr Surg 2012;47:1640–1645.

    Article  PubMed  Google Scholar 

  21. Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med 2012;31:3805–3820.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in metaanalysis. JAMA 2006;295:676–680.

    Article  CAS  PubMed  Google Scholar 

  23. Zintzaras E, Ioannidis JP. HEGESMA: genome search metaanalysis and heterogeneity testing. Bioinformatics 2005;21:3672–3673.

    Article  CAS  PubMed  Google Scholar 

  24. Qin JL, Wei H, Li LQ, Wang Y. The value of serum intestinal fatty acid binding protein in the diagnosis of necrotizing enterocolitis. Chin J Pediatr Surg 2013;34:590–594. [In Chinese]

    Google Scholar 

  25. Li C, Ren XY, Cai WX, Niu FH. Cytokines and intestinal fatty acid binding protein for early diagnosis and determination of the severity of necrotizing enterocolitis. Shandong Medical J 2013;53:50–51. [In Chinese]

    Google Scholar 

  26. Derikx JP, Evennett NJ, Degraeuwe PL, Mulder TL, Van Bijnen AA, Van Heurn LW, et al. Urine based detection of intestinal mucosal cell damage in neonates with suspected necrotising enterocolitis. Gut 2007;56:1473–1475.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Guthmann F, Börchers T, Wolfrum C, Wustrack T, Bartholomäus S, Spener F. Plasma concentration of intestinal-and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates. Mol Cell Biochem 2002;239:227–234.

    Article  CAS  PubMed  Google Scholar 

  28. Tan NS, Shaw NS, Vinckenbosch N, Liu P, Yasmin R, Desvergne B, et al. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol 2002;22:5114–5127.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Evennett N, Alexander N, Petrov M, Pierro A, Eaton S. A systematic review of serologic tests in the diagnosis of necrotizing enterocolitis. J Pediatr Surg 2009;44:2192–2201.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wen-Tong Zhang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Jiang, LF., Zhang, RP. et al. Clinical significance of FABP2 expression in newborns with necrotizing enterocolitis. World J Pediatr 12, 159–165 (2016). https://doi.org/10.1007/s12519-015-0035-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12519-015-0035-1

Keywords

Navigation